000 01326 a2200349 4500
005 20250515160847.0
264 0 _c20090402
008 200904s 0 0 eng d
022 _a1699-5848
024 7 _a10.14670/HH-24.493
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOkamoto, Kinya
245 0 0 _aBiomarkers for novel targeted therapies of hepatocellular carcinoma.
_h[electronic resource]
260 _bHistology and histopathology
_c04 2009
300 _a493-502 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
650 0 4 _aCarcinoma, Hepatocellular
_xblood supply
650 0 4 _aClinical Trials as Topic
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xblood supply
650 0 4 _aNeovascularization, Pathologic
650 0 4 _aReceptors, Vascular Endothelial Growth Factor
_xantagonists & inhibitors
650 0 4 _aSignal Transduction
650 0 4 _aVascular Endothelial Growth Factor A
_xmetabolism
700 1 _aNeureiter, Daniel
700 1 _aOcker, Matthias
773 0 _tHistology and histopathology
_gvol. 24
_gno. 4
_gp. 493-502
856 4 0 _uhttps://doi.org/10.14670/HH-24.493
_zAvailable from publisher's website
999 _c18667232
_d18667232